title: Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastoma.
abstract: Neuroblastoma at stage IVS, defined by dissemination to specific tissues and age <1 year at diagnosis, regularly follows spontaneous regression without cytotoxic treatment. To uncover the molecular characteristics of this subtype, Serial Analysis of Gene Expression (SAGE) profiles from stage IVS and fatal stage IV tumors were compared. A SAGE tag (GCAACTTAAC) was detected that was overrepresented in stage IVS disease and that had no reliable match in current National Center for Biotechnology Information databases of SAGE profiles, thus pointing to a novel gene. The corresponding gene, which maps to chromosome 4q33-34, was identified using a modified 3'- and 5'-rapid amplification of cDNA ends PCR and was designated as DEIN (differentially expressed in neuroblastoma). The gene comprises five transcript variants and its sequence overlaps with expressed sequences of the yet uncharacterized UniGene cluster Hs.61435. DEIN exhibits nucleotide sequence conservation over a broad range of species with an overall homology of 65% between human and mouse. As none of the predicted amino acid sequences is homologous to known proteins, it remains to be determined whether DEIN represents a coding or noncoding RNA. Northern blot analysis and semiquantitative reverse transcription-PCR showed high DEIN expression in neuroblastoma, whereas expression was absent or weak in most normal adult tissues. Analysis of 121 primary neuroblastomas by real-time reverse transcription-PCR revealed a strong association with age at diagnosis <1 year and particularly with stage IVS disease (both P < 0.001). The characteristic expression pattern of DEIN suggests a specific role of this gene in the unique biology of stage IVS tumors and may help to molecularly define this special subtype of neuroblastoma.
authors.affiliation: Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Kerpener Strasse 62, 50924 Cologne, Germany.
authors.forename: Harald
authors.initials: H
authors.lastname: Voth
authors.forename: André
authors.initials: A
authors.lastname: Oberthuer
authors.forename: Thorsten
authors.initials: T
authors.lastname: Simon
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Kahlert
authors.forename: Frank
authors.initials: F
authors.lastname: Berthold
authors.forename: Matthias
authors.initials: M
authors.lastname: Fischer
mesh_terms: D000328:Adult; D001483:Base Sequence; D015152:Blotting, Northern; D018076:DNA, Complementary; D015972:Gene Expression Regulation, Neoplastic; D014644:Genetic Variation; D006801:Humans; D007223:Infant; D053208:Kaplan-Meier Estimate; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000235:genetics*; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology*
chemical_list: D018076:DNA, Complementary; D009363:Neoplasm Proteins